You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Nucleos(t)ide therapy

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic Hepatitis B Trial in Worldwide (ABI-H0731, SOC NrtI)

Terminated
  • Chronic Hepatitis B
  • Beverly Hills, California
  • +23 more
Mar 22, 2022

Liver Cirrhosis, Portal Hypertension Trial in China (Carvedilol 12.5 MG)

Recruiting
  • Liver Cirrhosis
  • Portal Hypertension
  • Carvedilol 12.5 MG
  • Beijing, Beijing, China
  • +13 more
Aug 19, 2021

Chronic Hepatitis b Trial in Auckland (AB-101, Placebo, Nucleos(t)ide Analogue)

Not yet recruiting
  • Chronic Hepatitis b
  • Auckland, New Zealand
    New Zealand Clinical Research Auckland
Jul 26, 2023

Multiple Myeloma Trial in New York (Ide-cel (bb2121))

Recruiting
  • Multiple Myeloma
  • Ide-cel (bb2121)
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jul 6, 2022

Chronic Hepatitis b Trial in Guangzhou (Vitamin D)

Completed
  • Chronic Hepatitis b
  • Vitamin D
  • Guangzhou, Guangdong, China
    Department of Infectious Diseases, The Third Affliated Hospital
Mar 2, 2023

Chronic Hepatitis B Trial in Hong Kong (Stop current treatment (anti-HBV neucleos(t)ides), Keep current treatment (anti-HBV

Recruiting
  • Chronic Hepatitis B
  • Stop current treatment (anti-HBV neucleos(t)ides)
  • Keep current treatment (anti-HBV neucleos(t)ides)
  • Hong Kong, Hong Kong SAR, Hong Kong
    Humanity & Health Research Centre
Mar 16, 2022

HIV-1-infection Trial in Kampala, Harare (GS-9131, BIC, TAF)

Terminated
Has Results
  • HIV-1-infection
  • Kampala, Uganda
  • +1 more
Dec 7, 2020

Chronic Hepatitis B Trial (RO7565020, Placebo, Nucleos(t)ide analogue (NUC) treatment)

Not yet recruiting
  • Chronic Hepatitis B
  • (no location specified)
Feb 28, 2023

Hepatitis D, Chronic Trial in Worldwide (JNJ-73763989, Placebo, Entecavir (ETV) monohydrate)

Active, not recruiting
  • Hepatitis D, Chronic
  • Redwood City, California
  • +68 more
Jan 17, 2023

Real-world Study Optimizing Nucleotide-analogues

Recruiting
  • Hepatitis B, Chronic
  • Hefei, Anhui, China
  • +43 more
Jul 7, 2023

Chronic Hepatitis b, NAFLD, Cirrhosis Trial in Hong Kong (Empagliflozin 10 MG, Placebo pills)

Recruiting
  • Chronic Hepatitis b
  • +5 more
  • Empagliflozin 10 MG
  • Placebo pills
  • Hong Kong, Hong Kong, China, Hong Kong
    The University of Hong Kong/Queen Mary Hospital
May 31, 2022

Chronic Hepatitis b Trial in China (Stop NAs therapy)

Recruiting
  • Chronic Hepatitis b
  • Stop NAs therapy
  • Beijing, Beijing, China
  • +4 more
Aug 17, 2020

Chronic Hepatitis B Trial in Singapore (stopping nucleos(t)ide therapy, Continue nucleos(t)ide analogue)

Unknown status
  • Chronic Hepatitis B
  • stopping nucleos(t)ide therapy
  • Continue nucleos(t)ide analogue
  • Singapore, Singapore
    National University Hospital
Sep 24, 2019

Hepatitis B, Chronic Trial in Worldwide (JNJ-73763989, PD-1 inhibitor, Tenofovir Disoproxil)

Recruiting
  • Hepatitis B, Chronic
  • Vancouver, British Columbia, Canada
  • +31 more
Jan 17, 2023

Chronic Hepatitis B Trial in China (Peginterferon alfa-2b injection, TDF)

Active, not recruiting
  • Chronic Hepatitis B
  • Peginterferon alfa-2b injection
  • TDF
  • Beijing, China
  • +32 more
Jul 17, 2022

Hepatitis B, Chronic Trial in Guangzhou (pegylated interferon-alfa)

Recruiting
  • Hepatitis B, Chronic
  • pegylated interferon-alfa
  • Guangzhou, Guangdong, China
    Department of Infectious Diseases, The Third Affliated Hospital
Dec 20, 2021

Hepatitis B Virus Infection Trial in Changsha (Standard antiviral therapy)

Recruiting
  • Hepatitis B Virus Infection
  • Standard antiviral therapy
  • Changsha, Hunan, China
    Department of Infectious Disease, Xiangya Hospital, Central Sout
May 22, 2022

Hepatitis B Trial in Worldwide (GSK3228836, PegIFN, NA therapy)

Active, not recruiting
  • Hepatitis B
  • Sacramento, California
  • +48 more
Jan 19, 2023

Chronic Hepatitis b Trial in Belgium (Cessation of ongoing treatment)

Not yet recruiting
  • Chronic Hepatitis b
  • Cessation of ongoing treatment
  • Aalst, Belgium
  • +17 more
Feb 26, 2021

Chronic HBV Infection Trial in Canada, United States (EDP-514, Placebo)

Completed
  • Chronic HBV Infection
  • Coronado, California
  • +14 more
Jan 6, 2022

Nucleos(t)Ide Analogs (NUC) Therapy Among Naive CHB China

Completed
  • Chronic Hepatitis B
    • Beijing, Beijing, China
    • +54 more
    Jul 13, 2020

    Chronic Hepatitis B Virus Infection Manage

    Completed
    • Chronic HBV Infection
    • Drug Withdrawal
    • serum HBV RNA
    • (no location specified)
    Jan 30, 2021

    Chronic Hepatitis B Trial run by the NIDDK (Peginterferon alfa-2a)

    Completed
    Has Results
    • Chronic Hepatitis B
    • Peginterferon alfa-2a
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Aug 23, 2019

    Hepatitis B Trial in Worldwide (JNJ-73763989, JNJ-56136379, Entecavir (ETV))

    Active, not recruiting
    • Hepatitis B
    • Baltimore, Maryland
    • +9 more
    Jan 17, 2023

    Chronic Hepatitis B Trial in Taipei (Engerix-B, Tenofovir, Entecavir)

    Completed
    • Chronic Hepatitis B
    • Taipei, Taiwan
      Chang Gung Memorial Hospital
    Jul 28, 2019